Related references
Note: Only part of the references are listed.Patiromer for Treatment of Hyperkalemia in the Emergency Department: A Pilot Study
Zubaid Rafique et al.
ACADEMIC EMERGENCY MEDICINE (2020)
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Catherine M. Clase et al.
KIDNEY INTERNATIONAL (2020)
Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double-blind, Placebo-controlled Study (ENERGIZE)
W. Frank Peacock et al.
ACADEMIC EMERGENCY MEDICINE (2020)
Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate
Yao Qiao et al.
JAMA INTERNAL MEDICINE (2020)
Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project
Alessandro Gasparini et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia A 12-Month Phase 3 Study
Bruce S. Spinowitz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Novel potassium binders as enabling therapy in heart failure
Javed Butler et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology
Petar M. Seferovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia From the Electrocardiogram
Conner D. Galloway et al.
JAMA CARDIOLOGY (2019)
Physiology and Pathophysiology of Potassium Homeostasis: Core Curriculum 2019
Biff F. Palmer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
Steven Fishbane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients-A population-based cohort study
Kasper Adelborg et al.
PLOS ONE (2019)
Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
J. Ariana Noel et al.
JAMA INTERNAL MEDICINE (2019)
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal et al.
LANCET (2019)
Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis Patients
Csaba P. Kovesdy et al.
KIDNEY INTERNATIONAL REPORTS (2019)
Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE
Simon D. Roger et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors
Juan Tamargo et al.
CARDIOVASCULAR DRUGS AND THERAPY (2018)
Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists
Marco Trevisan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF
Joost C. Beusekamp et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry
Gianluigi Savarese et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Revisiting RAAS blockade in CKD with newer potassium-binding drugs
Panagiotis I. Georgianos et al.
KIDNEY INTERNATIONAL (2018)
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
Mark Bounthavong et al.
PHARMACOECONOMICS (2018)
REAL WORLD EVIDENCE FOR TREATMENT OF HYPERKALEMIA IN THE EMERGENCY DEPARTMENT (REVEAL-ED): A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY
W. Frank Peacock et al.
JOURNAL OF EMERGENCY MEDICINE (2018)
Efficacy of mineralocorticoid receptor antagonists in postmyocardial infarction patients with or without left ventricular dysfunction A meta-analysis of randomized controlled trials
Yan Xu et al.
MEDICINE (2018)
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Giuseppe M. C. Rosano et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2018)
Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure
O. Ola Vedin et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Electrolyte and Acid-Base Disorders in the Renal Transplant Recipient
Vaishnavi Pochineni et al.
FRONTIERS IN MEDICINE (2018)
Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN
Bertram Pitt et al.
ESC HEART FAILURE (2018)
FO012NORMALIZATION OF SERUM BICARBONATE WITH SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) IN THE PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED HARMONIZE STUDY
Angel de Francisco et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Associations of serum potassium levels with mortality in chronic heart failure patients
Mette Aldahl et al.
EUROPEAN HEART JOURNAL (2017)
Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
Erik Nilsson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Ventricular action potential adaptation to regular exercise: role of β-adrenergic and KATP channel function
Xinrui Wang et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Sarcoplasmic reticulum Ca2+, Mg2+, K+, and Cl- concentrations adjust quickly as heart rate changes
Claudio Berti et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Palatability and physical properties of potassium-binding resin RDX7675: comparison with sodium polystyrene sulfonate
Vanessa Zann et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
Ghassan Bandak et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Diagnosis and treatment of hyperkalemia
Biff F. Palmer et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2017)
Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension
Csaba P. Kovesdy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials
Chenhui Tai et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes
Allan J. Collins et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Establishing evidence-based thresholds and laboratory practices to reduce inappropriate treatment of pseudohyperkalemia
Pratistha Ranjitkar et al.
CLINICAL BIOCHEMISTRY (2017)
Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort
Taehee Kim et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review
Mario V. Beccari et al.
CORE EVIDENCE (2017)
Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction
Anna Grodzinsky et al.
AMERICAN JOURNAL OF MEDICINE (2016)
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice
Jonathan G. Howlett et al.
CANADIAN JOURNAL OF CARDIOLOGY (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer
Murray Epstein et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System
Alex R. Chang et al.
HYPERTENSION (2016)
Achieving the Benefits of a High-Potassium, Paleolithic Diet, Without the Toxicity
Biff F. Palmer et al.
MAYO CLINIC PROCEEDINGS (2016)
Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease
Georges N. Nakhoul et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD
Laurence Lepage et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Serum potassium levels as an outcome determinant in acute medical admissions
Richard Conway et al.
CLINICAL MEDICINE (2015)
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease The AMETHYST-DN Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
David A. Bushinsky et al.
KIDNEY INTERNATIONAL (2015)
Sodium Zirconium Cyclosilicate for Urgent Therapy of Severe Hyperkalemia
Mikhail Kosiborod et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
Matthew R. Weir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sodium Zirconium Cyclosilicate in Hyperkalemia
David K. Packham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction
Maria Lukacs Krogager et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2015)
Potassium-Binding Resins Associations with Serum Chemistries and interdialytic weight Gain in Hemodialysis Patients
Michel Jadoul et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy Results From the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
Patrick Rossignol et al.
CIRCULATION-HEART FAILURE (2014)
ESC Guidelines on diabetes, pre- diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary
Lars Ryden et al.
DIABETES & VASCULAR DISEASE RESEARCH (2014)
Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia The HARMONIZE Randomized Clinical Trial
Mikhail Kosiborod et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
Miklos Z. Molnar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Management of hyperkalaemia in chronic kidney disease
Csaba P. Kovesdy
NATURE REVIEWS NEPHROLOGY (2014)
Characterization of Structure and Function of ZS-9, α K+ Selective Ion Trap
Fiona Stavros et al.
PLOS ONE (2014)
Gastrointestinal Adverse Events with Sodium Polystyrene Sulfonate (Kayexalate) Use: A Systematic Review
Ziv Harel et al.
AMERICAN JOURNAL OF MEDICINE (2013)
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
EUROPEAN HEART JOURNAL (2013)
Temporal Trends and Predictors in the Use of Aldosterone Antagonists Post-Acute Myocardial Infarction
Andrew N. Rassi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Acid-Base and Potassium Homeostasis
L. Lee Hamm et al.
SEMINARS IN NEPHROLOGY (2013)
Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission
Jamie L. Fleet et al.
BMJ OPEN (2012)
Severe hyperkalemia requiring hospitalization: predictors of mortality
Jung Nam An et al.
CRITICAL CARE (2012)
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
Bertram Pitt et al.
EUROPEAN HEART JOURNAL (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study
Sonal Korgaonkar et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Lisa M. Einhorn et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Molecular basis of funny current (If) in normal and failing human heart
Francesca Stillitano et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Enhanced large intestinal potassium permeability in end-stage renal disease
T Mathialahan et al.
JOURNAL OF PATHOLOGY (2005)
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
BF Palmer
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data
TH Jafar et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
